Curis stock after hours uchxipj

Curis stock after hours

13.03.2021

Coty77528

Find the latest Curis, Inc. (CRIS) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Curis (CRIS) Stock Forums - Investing.com Jan 30, 2020 · Frequency. Recurring Once. Follow Curis's earnings. For all future releases Just for the upcoming release Send me a reminder 1 trading day before Has Curis (CRIS) Outpaced Other Medical Stocks This Year ... Investors focused on the Medical space have likely heard of Curis , but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to Curis, Inc. (NASDAQ:CRIS) Slumps 8% After Public Offering ...

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes.

Curis, Inc. to Host Earnings Call ACCESSWIRE. Thursday, March 12, 2020. 08:00 AM ET. Curis to Release Fourth Quarter and Year-End 2019 Financial Results and Hold Conference Call on March 19, 2020 PR Newswire - PRF. Thursday, February 27, 2020. 08:01 AM ET. Curis Announces $30 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC Curis Inc. (CRIS) Stock Quote | Price Chart | Volume Chart

Curis, Inc. (CRIS) stock forum & discussion – Yahoo Finance

Stock analysis for Roche Holding AG (ROG:SIX Swiss Ex) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering · STOCKS Biotech Premarket Movers: Spectrum, BioCryst, Curis · By Armie Margaret Spectrum pharmaceuticals (sppi) stock slumps on fda ruling · By Rachel 13 Mar 2012 The stock is currently trading at ~$3.40, well below the close prior to the news. ahead of the scheduled PDUFA date (for instance, Curis (NASDAQ:CRIS)). If the approval announcement is after hours or intra-day, sell at the 16 Mar 2019 The stock has lost more than 80% of its value in the past three years. Shares of tiny biotech firm Curis (CRIS) have been a disappointment lately, losing more they'd all been going after inflammation but then publications came out showing and no plans to initiate any positions within the next 72 hours. 27 Feb 2020 The stock gained 11.48% to $6.70 in after-hours trading. Natera Inc's (NASDAQ: NTRA) fourth-quarter revenues climbed 24% to $67 million The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, May 29th 2018. An investor that had 100 shares of Curis stock

Read the latest StockTalks, investment ideas, and community discussion on Curis, Inc. (CRIS).

Curis, Inc. (CRIS) Stock Message Board - InvestorsHub Dec 06, 2019 · Curis, Inc., a drug discovery and development company, focuses on the research and development of cancer therapeutics. The company, under collaboration with Genentech, Inc., is conducting a pivotal Phase II clinical trial on its lead molecule, GDC-0449 in advanced basal cell carcinoma patients, as well as various Phase II clinical trials in CURIS Stock Quote - Stock Price Today

Here's a roundup of top developments in the biotech space over the last 24 hours . Scaling The Peaks(Biotech Stocks Hitting 52-week highs on March 18)

Sep 15, 2017 · Curis, Inc. (NASDAQ:CRIS) Curis, Inc. (NASDAQ:CRIS) shares fell 8% after the biotechnology company announced the pricing of an underwritten public offering of 20 million shares of common stock.The company has also granted underwriters 30-day option to purchase an additional 3 million shares. The offering is set to close on September 18, 2017 subject to customary closing … CRIS Stock Quote of Curis Inc - InvestorPlace